US RESEARCH ROUNDUP-Amgen, Carmax, Pfizer
US RESEARCH ROUNDUP-Amgen, Carmax, Pfizer Nov 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Amgen, Carmax and Pfizer, on Wednesday.
HIGHLIGHTS
* Amgen Inc AMGN.O: Leerink Partners raises target price to $464 from $395 |
* Carmax Inc KMX.N: JP Morgan cuts target price to $65 from $70 |
* Pfizer PFE.N: Morgan Stanley cuts target price to $26 from $28 |
* Supernus SUPN.O: Piper Sandler resumes coverage with overweight rating; PT $47 |
* Yum Brands YUM.N: TD Cowen raises target price to $180 from $177 |
Following is a summary of research actions on US companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Addus Homecare ADUS.O: Barclays raises target price to $101 from $96 |
* Adm ADM.N: JP Morgan raises to neutral from underweight |
* Adm ADM.N: Stephens cuts target price to $75 from $85 |
* Adobe Inc ADBE.O: Citigroup cuts to sell from neutral; cuts PT to $207 from $250 |
* Adtran Holdings ADTN.O: Needham cuts target price to $9 from $14 |
* Advanced Micro Devices AMD.O: D.A. Davidson raises PT to $600 from $550 |
* Advanced Micro Devices AMD.O: HSBC raises target price to $540 from $500 |
* Advanced Micro Devices AMD.O: JP Morgan raises target price to $575 from $550 |
* Advanced Micro Devices AMD.O: Melius Research raises PT to $650 from $600 |
* Advanced Micro Devices AMD.O: Mizuho cuts target price to $610 from $705 |
* Advanced Micro Devices AMD.O: Morgan Stanley raises PT to $550 from $510 |
* Advanced Micro Devices AMD.O: Piper Sandler raises target price to $650 from $600 |
* Advanced Micro Devices AMD.O: Raymond James raises PT to $649 from $641 |
* Advanced Micro Devices AMD.O: Stifel raises target price to $725 from $700 |
* Advanced Micro Devices AMD.O: Wells Fargo cuts target price to $650 from $700 |
* Alkermes Plc ALKS.O: H.C. Wainwright raises target price to $50 from $43 |
* American Savings Bank Na ASBH.N: Stephens raises target price to $22 from $21 |
* American Well AMWL.N: Stifel raises target price to $12 from $11 |
* American Well AMWL.N: Wells Fargo raises target price to $18 from $16 |
* Ametek AME.N: BMO raises target price to $302 from $282 |
* Ametek AME.N: Mizuho cuts target price to $275 from $285 |
* Ametek AME.N: RBC raises target price to $308 from $291 |
* Amgen AMGN.O: BofA Global Research raises PT to $347 from $328 |
* Amgen AMGN.O: Canaccord Genuity raises target price to $440 from $384 |
* Amgen AMGN.O: JP Morgan raises target price to $425 from $350 |
* Amgen AMGN.O: Leerink Partners raises target price to $464 from $395 |
* Amgen AMGN.O: Morgan Stanley raises target price to $410 from $359 |
* Amgen AMGN.O: Oppenheimer raises target price to $520 from $480 |
* Amgen AMGN.O: RBC raises target price to $470 from $430 |
* Amgen AMGN.O: Scotiabank raises target price to $530 from $500 |
* Amgen AMGN.O: TD Cowen raises target price to $531 from $452 |
* Amgen AMGN.O: Truist Securities raises target price to $398 from $380 |
* Amgen AMGN.O: Wells Fargo raises target price to $460 from $430 |
* Amgen Inc AMGN.O: Citigroup raises target price to $465 from $405 |
* Amneal pharma AMRX.O: JP Morgan raises target price to $25 from $24 |
* Amneal pharma AMRX.O: Leerink Partners raises target price to $25 from $23 |
* Apollo APO.N: JP Morgan raises target price to $157 from $153 |
* Apollo APO.N: KBW cuts target price to $130 from $135 |
* Apollo APO.N: RBC cuts target price to $138 from $146 |
* Apollo APO.N: TD Cowen cuts target price to $136 from $154 |
* Apollo Global Management APO.N: Barclays cuts target price to $156 from $157 |
* Aptiv Plc APTV.N: Barclays cuts target price to $53 from $60 |
* Arista Networks ANET.N: Barclays cuts target price to $236 from $289 |
* Arista Networks ANET.N: JP Morgan raises target price to $270 from $250 |
* Arista Networks ANET.N: Melius Research raises target price to $305 from $275 |
* Arista Networks ANET.N: Morgan Stanley raises target price to $230 from $220 |
* Arista Networks ANET.N: Wells Fargo cuts target price to $245 from $255 |
* Arvinas ARVN.O: Leerink Partners cuts target price to $8 from $9 |
* Astera Labs ALAB.O: Jefferies cuts target price to $350 from $450 |
* Astera Labs ALAB.O: Needham cuts target price to $300 from $425 |
* Astera Labs ALAB.O: RBC cuts target price to $400 from $500 |
* Astera Labs ALAB.O: Stifel cuts target price to $370 from $460 |
* Astera Labs ALAB.O: Susquehanna cuts target price to $258 from $310 |
* Astera Labs ALAB.O: TD Cowen cuts target price to $225 from $300 |
* Atlas Energy Solutions AESI.N: Piper Sandler cuts target price to $13 from $15 |
* Atricure ATRC.O: Canaccord Genuity raises target price to $67 from $55 |
* Atricure ATRC.O: JP Morgan raises target price to $62 from $36 |
* Atricure ATRC.O: Needham raises target price to $70 from $64 |
* Atricure ATRC.O: Piper Sandler raises target price to $70 from $60 |
* Atricure ATRC.O: Stifel raises target price to $70 from $65 |
* Autonation AN.N: JP Morgan cuts to neutral from overweight |
* Axsome Therapeutics AXSM.O: Mizuho cuts target price to $272 from $284 |
* Ball BALL.N: JP Morgan cuts to neutral from overweight |
* Ball BALL.N: Mizuho raises target price to $75 from $72 |
* Beam Therapeutics BEAM.O: Jefferies raises target price to $49 from $41 |
* Biomarin Pharmaceutical BMRN.O: JP Morgan cuts target price to $86 from $87 |
* Block XYZ.N: BofA Global Research raises PT to $117 from $115 |
* Block XYZ.N: Morgan Stanley raises target price to $82 from $80 |
* Block XYZ.N: Raymond James raises target price to $100 from $97 |
* Block XYZ.N: RBC raises target price to $103 from $95 |
* Block XYZ.N: Scotiabank raises target price to $89 from $82 |
* Block XYZ.N: Susquehanna raises target price to $110 from $100 |
* Block XYZ.N: TD Cowen raises target price to $109 from $105 |
* Bloom Energy BE.N: Barclays cuts target price to $289 from $316 |
* Bloom Energy BE.N: Barclays raises to overweight from equal-weight |
* Booking Holdings BKNG.O: B. Riley cuts target price to $265 from $274 |
* Booking Holdings BKNG.O: Barclays cuts target price to $170 from $210 |
* Booking Holdings BKNG.O: BMO cuts target price to $245 from $250 |
* Booking Holdings BKNG.O: BofA Global Research cuts PT to $219 from $232 |
* Booking Holdings BKNG.O: Citigroup cuts target price to $220 from $236 |
* Booking Holdings BKNG.O: Evercore ISI cuts target price to $250 from $270 |
* Booking Holdings BKNG.O: HSBC cuts target price to $240 from $301 |
* Booking Holdings BKNG.O: JP Morgan cuts target price to $205 from $248 |
* Booking Holdings BKNG.O: Mizuho cuts target price to $205 from $240 |
* Booking Holdings BKNG.O: Morgan Stanley cuts target price to $200 from $230 |
* Booking Holdings BKNG.O: Piper Sandler cuts target price to $200 from $215 |
* Booking Holdings BKNG.O: RBC cuts target price to $205 from $220 |
* Booking Holdings BKNG.O: Wells Fargo cuts target price to $179 from $190 |
* Brc Inc BRCC.N: Telsey Advisory Group cuts target price to $13 from $25 |
* Broadridge Financial Solutions BR.N: JP Morgan raises PT to $201 from $191 |
* Broadridge Financial Solutions BR.N: Morgan Stanley raises PT to $181 from $176 |
* Broadridge Financial Solutions BR.N: Raymond James cuts PT to $230 from $240 |
* Calix CALX.N: JP Morgan cuts target price to $50 from $58 |
* Camping World Holdings CWH.N: BMO cuts target price to $8 from $10 |
* Carmax KMX.N: JP Morgan cuts target price to $65 from $70 |
* Carmax KMX.N: Mizuho raises target price to $50 from $43 |
* Celanese CE.N: Barclays raises target price to $57 from $49 |
* Celanese CE.N: BofA Global Research raises PT to $66 from $63 |
* Celanese CE.N: JP Morgan raises target price to $77 from $76 |
* Ceribell CBLL.O: Canaccord Genuity raises target price to $33 from $26 |
* Cinemark Holdings CNK.N: Stonex raises target price to $45 from $40 |
* Cinemark Holdings CNK.N: Wells Fargo raises target price to $42 from $34 |
* Coastal Financial (Everett) CCB.O: Stephens raises PT to $60 from $54 |
* Columbus Mckinnon CMCO.O: JP Morgan raises PT to $30 from $29 |
* Community Health Systems CYH.N: Barclays cuts target price to $2 from $2.5 |
* Corcept Therapeutics CORT.O: Piper Sandler ups PT to $173 from $165 |
* Core & Main Inc CNM.N: Jefferies initiates coverage with buy rating; PT $53 |
* Coreweave CRWV.O: Citigroup cuts target price to $128 from $159 |
* Coupang CPNG.N: Citigroup raises to buy from neutral |
* Coupang CPNG.N: Mizuho cuts target price to $21 from $22 |
* Crescent Energy Company CRGY.N: JP Morgan raises target price to $23 from $21 |
* Crown Holdings CCK.N: JP Morgan cuts to neutral from overweight |
* Cullinan Therapeutics CGEM.O: Guggenheim assumes coverage with buy rating |
* Cullinan Therapeutics CGEM.O: Guggenheim assumes coverage with PT $35 |
* Diamondback Energy FANG.O: JP Morgan raises target price to $263 from $253 |
* Diamondback Energy FANG.O: Wells Fargo cuts target price to $244 from $263 |
* Diamondrock Hospitality DRH.O: Stifel raises target price to $15 from $13.50 |
* Digitalocean Holdings DOCN.N: Baird cuts target price to $130 from $165 |
* Digitalocean Holdings DOCN.N: Barclays cuts target price to $140 from $161 |
* Digitalocean Holdings DOCN.N: Canaccord Genuity cuts PT to $180 from $200 |
* Digitalocean Holdings DOCN.N: Morgan Stanley cuts PT to $150 from $175 |
* Dominion Energy D.N: BMO raises target price to $71 from $68 |
* Driven Brands Holdings DRVN.O: BTIG cuts to neutral from buy |
* Driven Brands Holdings DRVN.O: Canaccord Genuity cuts PT to $12 from $18 |
* Driven Brands Holdings DRVN.O: Canaccord Genuity cuts to hold from buy |
* Dt Midstream DTM.N: JP Morgan cuts target price to $142 from $144 |
* Duolingo DUOL.O: Barclays raises target price to $133 from $115 |
* Duolingo DUOL.O: D.A. Davidson raises target price to $180 from $175 |
* Duolingo DUOL.O: JP Morgan raises target price to $155 from $135 |
* Duolingo DUOL.O: Morgan Stanley raises target price to $145 from $140 |
* Duolingo DUOL.O: Needham raises target price to $165 from $145 |
* Duolingo DUOL.O: Scotiabank raises target price to $140 from $120 |
* Duolingo DUOL.O: Wedbush raises target price to $155 from $150 |
* Duolingo DUOL.O: Wells Fargo raises target price to $120 from $80 |
* Duolingo DUOL.O: Wells Fargo raises to equal weight from underweight |
* Dupont CTA_PA.N: BofA Global Research raises PT to $168 from $159 |
* Dupont DD.N: Barclays raises target price to $176 from $156 |
* Dupont DD.N: BofA Global Research raises PT to $168 from $159 |
* Dupont DD.N: Mizuho raises target price to $165 from $156 |
* Dynatrace DT.N: Barclays cuts target price to $61 from $71 |
* Dynatrace DT.N: Jefferies cuts target price to $65 from $75 |
* Dynatrace DT.N: JP Morgan cuts target price to $61 from $64 |
* Dynatrace DT.N: Needham cuts target price to $65 from $68 |
* Dynatrace DT.N: RBC cuts target price to $68 from $73 |
* Dynatrace DT.N: Wells Fargo cuts target price to $65 from $75 |
* Eastman Chemical Co EMN.N: RBC raises target price to $70 from $65 |
* Edwards Lifesciences EW.N: Truist Securities raises to buy from hold |
* Edwards Lifesciences EW.N: Truist Securities ups PT to $113 from $95 |
* Enpro NPO.N: JP Morgan raises target price to $440 from $430 |
* Equitable Holdings EQH.N: Mizuho raises target price to $67 from $66 |
* Everest Group Ltd. EG.N: KBW raises target price to $450 from $407 |
* Evertec EVTC.N: KBW raises target price to $42 from $38 |
* Expeditors International of Washington EXPD.N: JP Morgan ups PT to $220 from $214 |
* Expeditors International of Washington EXPD.N: Stephens ups PT to $240 from $220 |
* Expeditors Intl. of Washington EXPD.N: Barclays raises PT to $175 from $165 |
* Expro Group Holdings NV XPRO.N: Piper Sandler cuts target price to $15 from $16 |
* Exxon Mobil XOM.N: TD Cowen raises target price to $193 from $180 |
* Faeth Therapeutics FTH.O: Guggenheim cuts target price to $69 from $70 |
* Fedex Freight Holding Company Inc FDXF.N: BMO raises PT to $140 from $130 |
* Finwise Ban FINW.O: Stephens raises target price to $16 from $14 |
* First Bank (Hamilton) FRBA.O: Piper Sandler raises target price to $23 from $20 |
* Fiserv FISV.O: Barclays raises target price to $59 from $50 |
* Fiserv FISV.O: BMO raises target price to $57 from $48 |
* Fiserv FISV.O: JP Morgan raises target price to $65 from $60 |
* Fiserv FISV.O: KBW raises target price to $70 from $60 |
* Fiserv FISV.O: Morgan Stanley raises target price to $61 from $59 |
* Fiserv FISV.O: RBC raises target price to $70 from $65 |
* Fiserv FISV.O: TD Cowen raises target price to $59 from $49 |
* Flux Power Holdings FLUX.O: H.C. Wainwright cuts target price to $3 from $8 |
* Flywire FLYW.O: BTIG raises target price to $22 from $20 |
* Flywire FLYW.O: JP Morgan raises target price to $23 from $20 |
* Flywire FLYW.O: Morgan Stanley raises target price to $26 from $24 |
* Fortune Brands Innovations FBIN.N: Barclays cuts target price to $40 from $47 |
* Fortune Brands Innovations FBIN.N: D.A. Davidson cuts target price to $58 from $64 |
* Fortune Brands Innovations FBIN.N: Truist Securities cuts PT to $60 from $70 |
* Fortune Brands Innovations FBIN.N: Wells Fargo raises target price to $51 from $48 |
* Freshworks FRSH.O: Baird raises target price to $15 from $13 |
* Freshworks FRSH.O: Canaccord Genuity raises target price to $17 from $15 |
* Gaming and Leisure Properties GLPI.O: Mizuho cuts target price to $44 from $48 |
* Gartner IT.N: BMO raises target price to $231 from $212 |
* Gartner IT.N: Jefferies raises target price to $197 from $190 |
* Graphic Packaging Holding Company GPK.N: JP Morgan ups PT to $12 from $11.5 |
* Graphic Packaging Holding Company GPK.N: RBC raises target price to $12 from $9 |
* Group 1 Automotive GPI.N: JP Morgan cuts target price to $250 from $255 |
* Group 1 Automotive GPI.N: JP Morgan cuts to underweight from neutral |
* Hagerty HGTY.N: Wells Fargo raises target price to $17 from $14 |
* Hamilton Lane Inorated HLNE.O: JP Morgan cuts target price to $144 from $150 |
* Hamilton Lane Inorated HLNE.O: KBW raises PT to $120 from $116 |
* Healthstream HSTM.O: Canaccord Genuity raises target price to $32 from $29 |
* Hess Midstream LP HESM.N: Wells Fargo cuts target price to $34 from $40 |
* Huntsman HUN.N: Barclays raises target price to $11 from $10 |
* Ideaya Biosciences IDYA.O: Guggenheim cuts target price to $52 from $57 |
* Ideaya Biosciences IDYA.O: Leerink Partners cuts target price to $30 from $31 |
* Ideaya Biosciences IDYA.O: RBC cuts target price to $45 from $48 |
* Ideaya Biosciences IDYA.O: Truist Securities cuts target price to $57 from $59 |
* Idexx Laboratories IDXX.O: Jefferies raises target price to $770 from $705 |
* Incyte INCY.O: Leerink Partners cuts target price to $150 from $154 |
* Innovative Industrial Properties IIPR.N: Piper Sandler raises PT to $46 from $44 |
* Insmed INSM.O: H.C. Wainwright assumes coverage with buy rating; PT $220 |
* International Flavors & Fragrances IFF.N: Mizuho raises PT to $102 from $92 |
* IPG Photonics IPGP.O: Needham cuts target price to $105 from $120 |
* IPG Photonics IPGP.O: Stifel cuts target price to $100 from $125 |
* Isabella Bank ISBA.O: Piper Sandler raises target price to $50 from $43 |
* Isabella Bank ISBA.O: Piper Sandler raises to overweight from neutral |
* Jackson Financial JXN.N: Barclays raises target price to $154 from $151 |
* Kardigan KARD.O: H.C. Wainwright initiates coverage with buy rating ; PT $42 |
* Keurig DR Pepper KDP.O: JP Morgan raises target price to $41 from $39 |
* Keurig DR Pepper KDP.O: Piper Sandler raises target price to $41 from $38 |
* Keurig DR Pepper KDP.O: Wells Fargo raises target price to $40 from $37 |
* Knife River KNF.N: BofA Global Research cuts PT to $82 from $97 |
* Lab LH.N: Mizuho raises target price to $400 from $355 |
* Leidos LDOS.N: Stifel cuts target price to $138 from $142 |
* Leidos LDOS.N: TD Cowen cuts target price to $120 from $130 |
* Lendingtree TREE.O: JP Morgan cuts target price to $40 from $48 |
* Lindblad Expeditions Holdings LIND.O: Stifel raises target price to $43 from $37 |
* Louisiana-Pacific LPX.N: Barclays cuts target price to $86 from $88 |
* Madrigal Pharmaceuticals MDGL.O: Canaccord Genuity ups PT to $633 from $612 |
* Madrigal Pharmaceuticals MDGL.O: Truist Securities ups PT to $743 from $709 |
* Marathon Petroleum MPC.N: JP Morgan cuts PT to $430 from $448 |
* Marathon Petroleum MPC.N: Morgan Stanley raises target price to $458 from $453 |
* Marathon Petroleum MPC.N: Wells Fargo raises target price to $564 from $560 |
* Mastec MTZ.N: Jefferies cuts target price to $353 from $359 |
* Mink Therapeutics INKT.O: H.C. Wainwright assumes coverage with buy rating; PT $38 |
* Mirum Pharmaceuticals MIRM.O: H.C. Wainwright raisesPT to $202 from $200 |
* Mirum Pharmaceuticals MIRM.O: Leerink Partners cuts PT to $140 from $154 |
* Mosaic Co MOS.N: Mizuho cuts target price to $20 from $22 |
* Mvb Financial MVBF.O: KBW cuts target price to $31 from $34 |
* Neutron Holdings LIME.O: JP Morgan cuts target price to $33 from $38 |
* Neutron Holdings Inc LIME.O: Needham cuts target price to $29 from $36 |
* New Mountain Finance NMFC.O: Wells Fargo cuts target price to $7 from $7.5 |
* Niagen Bioscience NAGE.O: H.C. Wainwright cuts target price to $10 from $11 |
* Nucor NUE.N: Keybanc raises target price to $301 from $286 |
* Nurix Therapeutics NRIX.O: Jefferies cuts target price to $36 from $45 |
* Nurix Therapeutics NRIX.O: Wells Fargo cuts target price to $20 from $25 |
* Nuveen Churchill Direct Lending NCDL.N: Wells Fargo cuts PT to $11 from $12 |
* One Gas OGS.N: BTIG raises target price to $95 from $89 |
* One Gas OGS.N: Mizuho raises target price to $90 from $89 |
* One Gas OGS.N: Wells Fargo raises target price to $86 from $85 |
* Onemain Holdings OMF.N: Wells Fargo cuts target price to $62 from $65 |
* Oneok OKE.N: Mizuho raises target price to $101 from $95 |
* Oportun Financial OPRT.O: Stephens raises target price to $14 from $12 |
* Ovintiv OVV.N: Barclays raises target price to $80 from $75 |
* Ovintiv OVV.N: Mizuho raises target price to $82 from $75 |
* Palantir Technologies PLTR.O: Barclays raises target price to $273 from $265 |
* Pennymac Mortgage Investment Trust PMT.N: Wells Fargo cuts PT to $9 from $10 |
* People Incorporated PPLI.O: Citigroup cuts target price to $47 from $52 |
* People Inorated PPLI.O: Piper Sandler cuts target price to $43 from $48 |
* People Inorated PPLI.O: Stonex cuts target price to $58 from $63 |
* Pershing Square PS.N: RBC raises target price to $45 from $44 |
* Pfizer PFE.N: Morgan Stanley cuts target price to $26 from $28 |
* Pfizer PFE.N: RBC raises target price to $28 from $25 |
* Pinnacle West Capital PNW.N: Mizuho raises target price to $109 from $103 |
* PJT Partners PJT.N: KBW cuts target price to $155 from $159 |
* Procore Technologies PCOR.N: JP Morgan raises PT to $74 from $69 |
* Prudential Financial PRU.N: Barclays raises target price to $98 from $94 |
* Red Rock Resorts RRR.O: JP Morgan cuts target price to $64 from $71 |
* Red Rock Resorts RRR.O: Mizuho cuts target price to $62 from $74 |
* Red Rock Resorts RRR.O: Stifel cuts target price to $70 from $74 |
* Red Rock Resorts RRR.O: Stonex cuts target price to $60 from $78 |
* Redwood Trust RWT.N: Wells Fargo cuts target price to $3.5 from $6 |
* Revolve Group RVLV.N: Piper Sandler cuts target price to $26 from $30 |
* Revolve Group Inc RVLV.N: Morgan Stanley cuts target price to $25 from $29 |
* Revvity RVTY.N: Barclays raises target price to $175 from $160 |
* Revvity RVTY.N: Jefferies raises target price to $155 from $112 |
* Revvity RVTY.N: JP Morgan raises target price to $160 from $155 |
* Revvity RVTY.N: Leerink Partners raises target price to $180 from $160 |
* Revvity RVTY.N: RBC raises target price to $172 from $135 |
* Revvity RVTY.N: Stifel raises target price to $177 from $110 |
* Revvity RVTY.N: TD Cowen raises target price to $185 from $175 |
* Rhythm Pharmaceuticals RYTM.O: Needham cuts PT to $114 from $130 |
* River City Bank RCBC.O: KBW raises target price to $64 from $58 |
* Rxsight RXST.O: Needham cuts target price to $7 from $11 |
* Rxsight RXST.O: Piper Sandler cuts target price to $8 from $10 |
* Rxsight RXST.O: Wells Fargo cuts target price to $6 from $9 |
* Ryman Hospitality Properties RHP.N: Jefferies raises target price to $156 from $145 |
* Ryman Hospitality Properties RHP.N: JP Morgan raises PT to $143 from $138 |
* Safehold SAFE.N: RBC cuts target price to $12 from $13 |
* Septerna SEPN.O: Wells Fargo raises target price to $61 from $50 |
* Skyworks Solutions SWKS.O: BofA Global Research cuts PT to $72 from $78 |
* Skyworks Solutions SWKS.O: Mizuho cuts target price to $58 from $61 |
* Skyworks Solutions SWKS.O: RBC cuts target price to $80 from $95 |
* Skyworks Solutions SWKS.O: Stifel raises target price to $75 from $70 |
* Skyworks Solutions SWKS.O: Susquehanna cuts target price to $75 from $90 |
* Skyworks Solutions SWKS.O: TD Cowen raises target price to $75 from $65 |
* Skyworks Solutions Inc SWKS.O: Morgan Stanley cuts target price to $93 from $95 |
* Sonic Automotive SAH.N: Barclays cuts target price to $73 from $75 |
* Sonic Automotive SAH.N: JP Morgan cuts target price to $58 from $63 |
* Sonic Automotive Inc SAH.N: JP Morgan cuts target price to $58 from $63 |
* Sotera Health Company SHC.O: Barclays cuts target price to $20 from $22 |
* Sotera Health Company SHC.O: Piper Sandler cuts target price to $24 from $25 |
* Sprout Social SPT.O: Baird raises target price to $12 from $9 |
* Spyre Therapeutics Inc SYRE.O: Stifel raises target price to $131 from $123 |
* Starwood Property Trust STWD.N: KBW cuts PT to $15 from $16 |
* Sunoco LP SUN.N: Wells Fargo raises target price to $85 from $82 |
* Super Micro Computer SMCI.O: BofA Global Research raises PT to $39 from $38 |
* Super Micro Computer SMCI.O: Mizuho cuts target price to $36 from $43 |
* Supernus SUPN.O: Piper Sandler resumes coverage with overweight rating; PT $47 |
* Supernus SUPN.O: Stifel cuts target price to $37 from $55 |
* Talen Energy TLN.O: CIBC raises target price to $515 from $493 |
* Tarsus Pharmaceuticals TARS.O: H.C. Wainwright raises target price to $106 from $88 |
* Teladoc Health TDOC.N: Barclays raises target price to $9 from $7 |
* Tempus Ai TEM.O: Piper Sandler raises target price to $95 from $76 |
* Tenet Healthcare THC.N: Barclays raises target price to $297 from $271 |
* the Estée Lauder Companies EL.N: Barclays raises target price to $126 from $108 |
* the Marzetti Company MZTI.O: D.A. Davidson cuts target price to $110 from $130 |
* The Williams Companies WMB.N: Raymond James raises PT to $86 from $85 |
* Toast TOST.N: Morgan Stanley cuts target price to $42 from $45 |
* Travere Therapeutics TVTX.O: Guggenheim cuts target price to $78 from $89 |
* Ul Solutions ULS.N: Jefferies cuts target price to $110 from $120 |
* Ul Solutions ULS.N: Wells Fargo raises target price to $105 from $104 |
* Ultragenyx Pharmaceutical RARE.O: Canaccord Genuity cuts PT to $34 from $39 |
* Ultragenyx Pharmaceutical RARE.O: Wells Fargo raises target price to $19 from $18 |
* Unum Group UNM.N: Barclays cuts target price to $101 from $109 |
* Upstart Holdings UPST.O: Mizuho cuts target price to $35 from $45 |
* Upstart Holdings UPST.O: Morgan Stanley cuts target price to $24 from $35 |
* Upstart Holdings UPST.O: Needham cuts target price to $30 from $42 |
* Upstart Holdings UPST.O: Piper Sandler cuts target price to $35 from $51 |
* Upstart Holdings UPST.O: Stephens cuts target price to $24 from $26 |
* V VGID.PK: BofA Global Research raises PT to $87 from $85 |
* Versant Media Group VSNT.O: JP Morgan raises target price to $39 from $43 |
* Vertex Pharmaceuticals VRTX.O: Barclays raises target price to $626 from $617 |
* Vici Properties Inc VICI.N: Mizuho cuts target price to $26 from $27 |
* Viper Energy VNOM.O: JP Morgan raises target price to $57 from $55 |
* Waters WAT.N: Barclays raises target price to $530 from $500 |
* Waters WAT.N: JP Morgan raises target price to $470 from $435 |
* Waters WAT.N: Leerink Partners raises target price to $500 from $450 |
* Waters WAT.N: RBC raises target price to $525 from $475 |
* Waters WAT.N: Stifel raises target price to $470 from $420 |
* Xometry XMTR.O: Citigroup raises target price to $132 from $110 |
* Xometry XMTR.O: JP Morgan raises target price to $140 from $120 |
* Xometry XMTR.O: RBC raises target price to $117 from $100 |
* Xplr Infrastructure LP XIFR.N: Mizuho cuts target price to $11 from $13 |
* Xplr Infrastructure LP XIFR.N: RBC cuts target price to $12 from $14 |
* Yum Brands YUM.N: BMO cuts target price to $170 from $175 |
* Yum Brands YUM.N: RBC raises target price to $180 from $170 |
* Yum Brands YUM.N: TD Cowen raises target price to $180 from $177 |
* Zebra Technologies ZBRA.O: Barclays raises target price to $432 from $416 |
* Zebra Technologies ZBRA.O: Morgan Stanley raises PT to $380 from $360 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Apollo Global Management
See all newsThe AI boom teeters on a capital balancing act
US RESEARCH ROUNDUP-Amgen, Carmax, Pfizer
Apollo assets reach $1.07 trillion on alternative investment demand (updated)
Apollo Global Management, Inc. reports results for the quarter ended September 30 - Earnings Summary
Apollo Global Management, Inc. reports results for the quarter ended September 30 - Earnings Summary